The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...

In a significant achievement for identifying neurodegenerative diseases early, a team of US researchers has developed a new ...

A new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of ...

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy and guides personalised cancer treatment effectively.

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest impact. The tool could bring advanced diagnostic support to clinics.

The tool analyzes a fluorodeoxyglucose positron emission tomography (FDG-PET) scan, which shows how the brain uses glucose for energy. It then compares the scan to a large database of scans from ...

To investigate the accuracy of PET and MRI in women with advanced stage ovarian cancer to determine the feasibility of primary debulking surgery. What are the main results of the review? We identified ...

PET-CT requires injection of a weakly radioactive substance (FDG). The PET part of the scan identifies areas of the body that take up a lot of FDG (indicating possibly cancerous cells), and the CT ...

Multimodality imaging, such as 18 F-FDG PET/CT and PET/MRI, offers detailed information on the activity and composition of atherosclerotic plaques. 73 Importantly, 18 F-FDG PET enables the detection ...

Positron emission tomography (PET) with 18F-fludeoxyglucose (FDG) can visualize the spatial pattern of neurodegeneration-related glucose hypometabolism.We proposed the “MRI-styled PET”, leveraging ...

Conclusions: Metabolic indices from abbreviated dual time-point FDG-PET/MRI can differentiate pancreatic malignancy from pancreatitis and predict outcomes, outperforming other indices. This protocol ...